Evidence that type I osteoporosis results from enhanced responsiveness of bone to estrogen deficiency

Osteoporosis International

Volumn 14, Issue 9, 2003, Pages 728-733

  Riggs, B Lawrence ^a   Khosla, Sundeep ^a   Atkinson, Elizabeth J ^a   Dunstan, Colin R ^b   Melton III, L Joseph ^a  

^a MAYO CLINIC   (United States)

^b AMGEN INC   (United States)

Author keywords

Bone loss; Estradiol; Testosterone; Transdermal estrogen

Indexed keywords

DEOXYPYRIDINOLINE; ESTRADIOL; ESTROGEN; ESTRONE; MEDROXYPROGESTERONE ACETATE; OSTEOPROTEGERIN; SEX HORMONE; TESTOSTERONE;

ADULT; AGED; ARTICLE; CANCELLOUS BONE; CLINICAL ARTICLE; CONTROLLED STUDY; ESTROGEN DEFICIENCY; FEMALE; HUMAN; MENOPAUSE; OSTEOLYSIS; OSTEOPOROSIS; PRIORITY JOURNAL; RADIUS FRACTURE; VERTEBRA FRACTURE;

AGED; BONE RESORPTION; ESTRADIOL; ESTRONE; FEMALE; GLYCOPROTEINS; GONADAL STEROID HORMONES; HUMANS; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; OSTEOPROTEGERIN; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, TUMOR NECROSIS FACTOR; SPINAL FRACTURES; TESTOSTERONE;

EID: 0142086875     PISSN: 0937941X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00198-003-1437-9     Document Type: Article

References (20)

1. Riggs BL, Melton LJ III (1983) Evidence for two distinct syndromes of involutional osteoporosis. Am J Med 75:899-901
2. Riggs BL, Khosla S, Melton LJ (2001) The type I/type II model for involutional osteoporosis: update and modification based on new observations. In: Marcus R, Feldman D, Kelsey J (eds) Osteoporosis. Academic Press, San Diego, pp 9-58
3. Riggs BL, Khosla S, Melton LJ (2002) Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev 23:279-302
4. Eriksen EF, Hodgson SF, Eastell R, Cedel SL, O'Fallon WM, Riggs BL (1990) Cancellous bone remodeling in type I (postmenopausal) osteoporosis: quantitative assessment of rates of formation, resorption, and bone loss at tissue and cellular levels. J Bone Miner Res 5:311-319
5. Davidson BJ, Riggs BL, Wahner HW, Judd HL (1983) Endogenous cortisol and sex steroids in patients with osteoporotic spinal fractures. Obstet Gynecol 61:275-278
6. Marshall DH, Crilly RG, Nordin BEC (1977) Plasma androstenedione and oestrone levels in normal and osteoporotic postmenopausal women. Br Med J 2:1177-1179
7. Riggs BL, Ryan RJ, Wahner HW, Jiang N, Mattox VR (1973) Serum concentrations of estrogen, testosterone and gonadotropins in osteoporotic and non-osteoporotic postmenopausal women. J Clin Endocrinol Metab 36:1097-1099
8. Lufkin EG, Wahner HW, O'Fallon WM, Hodgson SF, Kotowicz MA, Lane AW, Judd HL, Caplan RH, Riggs BL (1992) Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann Int Med 117:1-9
9. Khosla S, Peterson JM, Egan K, Jones JD, Riggs BL (1994) Circulating cytokine levels in osteoporotic and normal women. J Clin Endocrinol Metab 79:707-711
10. Khosla S, Arrighi HM, Melton LJ III, Atkinson EJ, O'Fallon WM, Dunstan C, Riggs BL (2002) Correlates of osteoprotegerin levels in women and men. Osteoporos Int 13:394-399
11. Cummings SR, Browner WS, Bauer D, Stone K, Ensrud K, Jamal S, Ettinger B (1998) Endogenous hormones and the risk of hip and vertebral fractures among older women. N Engl J Med 339:733-738
12. Ettinger B, Pressman A, Sklarin P, Bauer DC, Cautley JA, Cummings SR (1998) Associations between low levels of serum estradiol, bone density, and fractures among elderly women: the study of osteoporotic fractures. J Clin Endocrinol Metab 83:2239-2243
13. Hofbauer LC, Khosla S, Dunstan CR, Lacey DL, Boyle WJ, Riggs BL (2000) The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res 15:2-12
14. Bekker PJ, Holloway D, Nakanishi A, Arrighi M, Leese PT, Dunstan CR (2001) The effect of a single dose of osteoprotegerin in postmenopausal women. J Bone Miner Res 16:348-360
15. Yano K, Tsuda N, Kobayashi F, Goto M, Harada A, Ikeda K, Higashio K, Yamada Y (1999) Immunological characterization of circulating osteoprotegerin/osteoclastogenesis inhibitory factor: increased serum concentrations in postmenopausal women with osteoporosis. J Bone Miner Res 14:518-527
16. Riggs BL, Arnaud CD, Jowsey J, Goldsmith RS, Kelly PJ (1973) Parathyroid function in primary osteoporosis. J Clin Invest 52:181-184
17. Hossain M, Smith DA, Nordin BEC (1970) Parathyroid activity and postmenopausal osteoporosis. Lancet 1:809-811
18. Gao P, Scheibel S, D'Amour P, John MR, Rao SD, Schmidt-Gayk H, Cantor TL (2001) Development of a novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone 1-84: implications for improvement of accurate assessment of parathyroid function. J Bone Miner Res 16:605-614
19. Heshmati HM, Khosla S, Robins SP, O'Fallon WM, Melton LJ III, Riggs BL (2002) Role of low levels of endogenous estrogen in regulation of bone resorption in late postmenopausal women. J Bone Miner Res 17:172-178
20. Salmen T, Heikkinen A-M, Mahonen A, Kroger H, Komulainen M, Saarikoski S, Honkanen R, Maenpaa PH (2000) Early postmenopausal bone loss is associated with PvuII estrogen receptor gene polymorphism in Finnish women: effect of hormone replacement therapy. J Bone Miner Res 15:315-321